臺大學術典藏 |
2022-09-14T01:29:27Z |
Management consensus guideline for hepatocellular carcinoma: 2020 update on surveillance, diagnosis, and systemic treatment by the Taiwan Liver Cancer Association and the Gastroenterological Society of Taiwan
|
Shao Y.-Y.; Wang S.-Y.; Lin S.-M.; Chen K.-Y.; Tseng J.-H.; Ho M.-C.; Lee R.-C.; Liang P.-C.; Liao L.-Y.; Huang K.-W.; Hu J.-T.; Liang J.-D.; Kee K.-M.; Lin C.-L.; Wang C.-K.; Lu S.-N.; Wang J.-H.; Lee W.-C.; CHIEN-HUNG CHEN; Liu C.-J.; Huang Y.-H.; Wang C.-C.; Wang T.-E.; Chuang P.-H.; Dai C.-Y.; Hsu C.; Chen S.-C.; Hsieh C.-H.; Diagnosis Group, Systemic Therapy Group |
臺大學術典藏 |
2022-09-09T04:21:41Z |
Direct comparison of biopsy techniques for hepatic malignancies
|
Huang S.-C.; Liang J.-D.; Hsu S.-J.; Hong T.-C.; Yang H.-C.; JIA-HORNG KAO |
臺大學術典藏 |
2022-08-19T00:21:05Z |
Induction of Bim expression contributes to the antitumor synergy between sorafenib and mitogen-activated protein kinase/extracellular signal-regulated kinase kinase inhibitor CI-1040 in hepatocellular carcinoma
|
Cheng A.-L.; CHIUN HSU; Wang D.-S.; Lu Y.-S.; Fan H.-H.; Ou D.-L.; Shen Y.-C.; Liang J.-D.; Liou J.-Y.; Yu S.-L. |
臺大學術典藏 |
2022-08-19T00:20:48Z |
Hepatitis B and C viruses are not risks for pancreatic adenocarcinoma
|
Chang M.-C.; Chen C.-H.; Liang J.-D.; Tien Y.-W.; CHIUN HSU; Wong J.-M.; Chang Y.-T. |
臺大學術典藏 |
2022-04-29T03:54:00Z |
The role of age in change in unmet supportive care needs in hepatocellular carcinoma patients during transition from hospital to home
|
Shun S.-C.; Lai Y.-H.; Hung Hung; Chen C.-H.; Liang J.-D.; Chou Y.-J. |
臺大學術典藏 |
2022-04-28T08:06:39Z |
Quality of life and its associated factors in patients with hepatocellular carcinoma receiving one course of transarterial chemoembolization treatment: A longitudinal study
|
Shun S.-C.; Chen C.-H.; Sheu J.-C.; Liang J.-D.; Yang J.-C.; YEUR-HUR LAI |
臺大學術典藏 |
2022-04-28T08:06:29Z |
The role of age in change in unmet supportive care needs in hepatocellular carcinoma patients during transition from hospital to home
|
Shun S.-C.; YEUR-HUR LAI; Hung H.; Chen C.-H.; Liang J.-D.; Chou Y.-J. |
臺大學術典藏 |
2022-04-14T07:20:26Z |
Hepatitis B reactivation during treatment of tyrosine kinase inhibitors�XExperience in 142 adult patients with chronic myeloid leukemia
|
Wang Y.-H.; Liang J.-D.; Sheng W.-H.; FENG-MING TIEN; Chen C.-Y.; Tien H.-F. |
臺大學術典藏 |
2022-03-04T08:22:48Z |
Quality of life and its associated factors in patients with hepatocellular carcinoma receiving one course of transarterial chemoembolization treatment: A longitudinal study
|
Shun S.-C.; Chen C.-H.; Sheu J.-C.; Liang J.-D.; JYH-CHIN YANG; Lai Y.-H. |
臺大學術典藏 |
2022-03-04T05:33:53Z |
Hepatic leiomyomatous neoplasm associated with Epstein Barr virus infection in an adult with acquired immunodeficiency syndrome
|
Wang M.-H.; CHEN-TU WU; Hung C.-C.; Liang J.-D.; Chen P.-J. |
臺大學術典藏 |
2022-02-23T02:12:41Z |
Percutaneous microwave coagulation therapy under ultrasound guidance for small hepatocellular carcinoma.
|
Liang J.D.; Yang P.M.; Huang G.T.; Lee H.S.; CHIEN-HUNG CHEN; Liang P.C.; Sheu J.C.; Chen D.S. |
臺大學術典藏 |
2022-02-23T02:12:35Z |
Differential DNA methylation associated with hepatitis B virus infection in hepatocellular carcinoma
|
Su P.-F.; Lee T.-C.; Lin P.-J.; Lee P.-H.; Jeng Y.-M.; CHIEN-HUNG CHEN; Liang J.-D.; Chiou L.-L.; Huang G.-T.; Lee H.-S. |
臺大學術典藏 |
2022-02-23T02:12:30Z |
Quality of life and its associated factors in patients with hepatocellular carcinoma receiving one course of transarterial chemoembolization treatment: A longitudinal study
|
Shun S.-C.; CHIEN-HUNG CHEN; Sheu J.-C.; Liang J.-D.; Yang J.-C.; Lai Y.-H. |
臺大學術典藏 |
2022-02-23T02:12:30Z |
Hepatocellular carcinoma with duodenal invasion and metastasis
|
Liang J.-D.; CHIEN-HUNG CHEN; Hsu S.-J.; Sheu J.-C.; Yang P.-M.; Lee H.-S.; Lee C.-Z.; Huang G.-T. |
臺大學術典藏 |
2022-02-23T02:12:26Z |
Hepatitis B and C viruses are not risks for pancreatic adenocarcinoma
|
Chang M.-C.; CHIEN-HUNG CHEN; Liang J.-D.; Tien Y.-W.; Hsu C.; Wong J.-M.; Chang Y.-T. |
臺大學術典藏 |
2022-02-23T02:12:25Z |
The role of age in change in unmet supportive care needs in hepatocellular carcinoma patients during transition from hospital to home
|
Shun S.-C.; Lai Y.-H.; Hung H.; CHIEN-HUNG CHEN; Liang J.-D.; Chou Y.-J. |
臺大學術典藏 |
2022-02-23T02:12:20Z |
Management consensus guideline for hepatocellular carcinoma: 2020 update on surveillance, diagnosis, and systemic treatment by the Taiwan Liver Cancer Association and the Gastroenterological Society of Taiwan
|
Shao Y.-Y.; Wang S.-Y.; Lin S.-M.; Chen K.-Y.; Tseng J.-H.; Ho M.-C.; Lee R.-C.; Liang P.-C.; Liao L.-Y.; Huang K.-W.; Hu J.-T.; Liang J.-D.; Kee K.-M.; Lin C.-L.; Wang C.-K.; Lu S.-N.; Wang J.-H.; Lee W.-C.; CHIEN-HUNG CHEN; Liu C.-J.; Huang Y.-H.; Wang C.-C.; Wang T.-E.; Chuang P.-H.; Dai C.-Y.; Hsu C.; Chen S.-C.; Hsieh C.-H.; Diagnosis Group, Systemic Therapy Group |
臺大學術典藏 |
2022-02-22T05:34:36Z |
Percutaneous microwave coagulation therapy under ultrasound guidance for small hepatocellular carcinoma.
|
Liang J.D.; Yang P.M.; Huang G.T.; Lee H.S.; CHIEN-HUNG CHEN; Liang P.C.; Sheu J.C.; Chen D.S. |
臺大學術典藏 |
2022-02-22T05:34:28Z |
Differential DNA methylation associated with hepatitis B virus infection in hepatocellular carcinoma
|
Su P.-F.; Lee T.-C.; Lin P.-J.; Lee P.-H.; Jeng Y.-M.; CHIEN-HUNG CHEN; Liang J.-D.; Chiou L.-L.; Huang G.-T.; Lee H.-S. |
臺大學術典藏 |
2022-02-22T05:34:22Z |
Hepatocellular carcinoma with duodenal invasion and metastasis
|
Liang J.-D.; CHIEN-HUNG CHEN; Hsu S.-J.; Sheu J.-C.; Yang P.-M.; Lee H.-S.; Lee C.-Z.; Huang G.-T. |
臺大學術典藏 |
2022-02-22T05:34:22Z |
Quality of life and its associated factors in patients with hepatocellular carcinoma receiving one course of transarterial chemoembolization treatment: A longitudinal study
|
Shun S.-C.; CHIEN-HUNG CHEN; Sheu J.-C.; Liang J.-D.; Yang J.-C.; Lai Y.-H. |
臺大學術典藏 |
2022-02-22T05:34:17Z |
Hepatitis B and C viruses are not risks for pancreatic adenocarcinoma
|
Chang M.-C.; CHIEN-HUNG CHEN; Liang J.-D.; Tien Y.-W.; Hsu C.; Wong J.-M.; Chang Y.-T. |
臺大學術典藏 |
2022-02-22T05:34:16Z |
The role of age in change in unmet supportive care needs in hepatocellular carcinoma patients during transition from hospital to home
|
Shun S.-C.; Lai Y.-H.; Hung H.; CHIEN-HUNG CHEN; Liang J.-D.; Chou Y.-J. |
臺大學術典藏 |
2022-02-22T05:34:10Z |
Management consensus guideline for hepatocellular carcinoma: 2020 update on surveillance, diagnosis, and systemic treatment by the Taiwan Liver Cancer Association and the Gastroenterological Society of Taiwan
|
Shao Y.-Y.; Wang S.-Y.; Lin S.-M.; Chen K.-Y.; Tseng J.-H.; Ho M.-C.; Lee R.-C.; Liang P.-C.; Liao L.-Y.; Huang K.-W.; Hu J.-T.; Liang J.-D.; Kee K.-M.; Lin C.-L.; Wang C.-K.; Lu S.-N.; Wang J.-H.; Lee W.-C.; CHIEN-HUNG CHEN; Liu C.-J.; Huang Y.-H.; Wang C.-C.; Wang T.-E.; Chuang P.-H.; Dai C.-Y.; Hsu C.; Chen S.-C.; Hsieh C.-H.; Diagnosis Group, Systemic Therapy Group |
臺大學術典藏 |
2022-01-24T09:30:58Z |
Management consensus guideline for hepatocellular carcinoma: 2020 update on surveillance, diagnosis, and systemic treatment by the Taiwan Liver Cancer Association and the Gastroenterological Society of Taiwan
|
Shao Y.-Y.; Wang S.-Y.; Lin S.-M.; Chen K.-Y.; Tseng J.-H.; Ho M.-C.; Lee R.-C.; Liang P.-C.; Liao L.-Y.; Huang K.-W.; Hu J.-T.; Liang J.-D.; Kee K.-M.; Lin C.-L.; Wang C.-K.; Lu S.-N.; Wang J.-H.; Lee W.-C.; Chen C.-H.; CHUN-JEN LIU; Huang Y.-H.; Wang C.-C.; Wang T.-E.; Chuang P.-H.; Dai C.-Y.; Hsu C.; Chen S.-C.; Hsieh C.-H.; Diagnosis Group, Systemic Therapy Group |